Midgard Science

abc biopply

Allschwil, Switzerland biopply.com From their website, Nov 2026

Work here? Claim this listing

About

abc biopply AG provides preclinical CRO services and assay licensing based on proprietary 3D CoSeedis humanized multi-organoid in-chip technology. It works with biotech and pharma clients on drug efficacy, safety, toxicity, resistance, biomarker development, and custom disease-model design from its sites in Allschwil, Basel and Solothurn, Switzerland.

Services

  • Preclinical CRO Services

    Validated preclinical services for drug efficacy, safety, toxicity, resistance, and biomarker development on clinically relevant multi-organoid disease models.

  • Service Packages

    Bundled assay sets for drug development questions such as efficacy, resistance, toxicity, safety, target validation, marker studies, omics, and study planning.

  • Assays

    Highly standardized and validated 3D CoSeedis in-chip assays for individual preclinical readouts and project-specific study needs.

  • Licenses

    In-licensing options for the company's assays, protocols, disease models, and technology for in-house use.

  • Custom-tailored model development

    Design and development of custom disease models, including characterization and biomarker discovery.

  • Integrated preclinical services

    Preclinical services that combine in vitro to in vivo work synchronized with humanized mouse models through partner laboratories.

  • Target validation package

    Package for target localization, binding, activation, tissue penetration, and cytotoxicity studies during drug development and optimization.

  • Rapid Drug Efficacy Check

    Package for rapid prediction of clinically relevant drug efficacy and dosage using 3D CoSeedis tumor models and dose-response readouts.

11 more services
  • Drug Safety Package
  • Drug Resistance Check
  • Personalized Efficacy Package
  • Personalized Toxicity Target and off-Target Package
  • Pathway Analysis Package
  • Drug Response Package
  • Cell Viability Package
  • Organoid service packages
  • Licensing of assays and protocols
  • Custom disease model development
  • Integrated preclinical study support
Turnaround
  • 10 weeks to result
  • 12 weeks to result
What to send
  • Choose a 3D CoSeedis tumor model
  • One drug - one target

Capabilities

Assays and studies
  • Toxicology
  • In vivo
  • Rodent models
  • Apoptosis
  • Co-culture
  • Cytotoxicity
17 more
  • Dose response
  • Drug efficacy
  • Tumor relapse
  • Histology
  • Live cell detection
  • Antibody penetration
  • Late stage cancer relapse
  • Colony forming
  • Off-target cytotoxicity
  • Drug penetration
  • Marker studies
  • Omics
  • IC50 determination
  • Drug efficacy assay
  • Drug safety assay
  • Toxicology assay
  • Drug resistance assay
Scale and capacity
Up to 1000 replicates
Therapeutic areas
  • Oncology
  • Neurology
  • Hepatology
  • Nephrology
  • Obesity
  • Cartilage
  • Renal

Instruments and platforms

  • 3D CoSeedis in chip technology
  • 3D CoSeedis™ chips

Modalities and species

Modalities
  • Organoid models
  • Multi-organoid disease models
  • Humanized mouse models
  • Patient-derived cells
  • Organoid
  • Humanized multi-organoid disease models
Species and models
  • 3D CoSeedis tumor models
  • Oncology
  • Neurology
  • Hepatic
  • Renal
  • Cartilage
6 more
  • Obesity
  • PDCs
  • Humanized mouse models
  • Patient tissues
  • Healthy tissues
  • Diseased tissues

Industries served

  • Biotech
  • Pharma

Details

Type
CRO
Founded
2018
Address
Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
Sites
  • Allschwil, Basel, Switzerland
  • Solothurn, Switzerland
Serves
Switzerland, EU, Canada, international, CH

Similar labs